These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18508594)

  • 41. Apolipoprotein E immunoreactivity in human and mouse olfactory bulb.
    Struble RG; Short J; Ghobrial M; Nathan BP
    Neurosci Lett; 1999 May; 267(2):137-40. PubMed ID: 10400231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE-/- mice.
    Chiba T; Ikeda M; Umegaki K; Tomita T
    Atherosclerosis; 2011 Dec; 219(2):545-51. PubMed ID: 21944698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
    Veinbergs I; Van Uden E; Mallory M; Alford M; McGiffert C; DeTeresa R; Orlando R; Masliah E
    Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy.
    Umar S; Partow-Navid R; Ruffenach G; Iorga A; Moazeni S; Eghbali M
    Biol Sex Differ; 2017; 8():9. PubMed ID: 28344760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of apoE deficiency during synaptic remodeling in the mouse olfactory bulb.
    Nwosu I; Gairhe S; Struble RG; Nathan BP
    Neurosci Lett; 2008 Aug; 441(3):282-5. PubMed ID: 18621483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apolipoprotein E receptors and amyloid expression are modulated in an apolipoprotein E-dependent fashion in response to hippocampal deafferentation in rodent.
    Petit-Turcotte C; Aumont N; Blain JF; Poirier J
    Neuroscience; 2007 Nov; 150(1):58-63. PubMed ID: 17935896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice.
    Chen J; Kuhlencordt P; Urano F; Ichinose H; Astern J; Huang PL
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):97-103. PubMed ID: 12524231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease.
    Buttini M; Akeefe H; Lin C; Mahley RW; Pitas RE; Wyss-Coray T; Mucke L
    Neuroscience; 2000; 97(2):207-10. PubMed ID: 10799751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
    Van Eck M; Van Dijk KW; Herijgers N; Hofker MH; Groot PH; Van Berkel TJ
    Atherosclerosis; 2001 Jan; 154(1):103-12. PubMed ID: 11137088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apolipoprotein E Exerts a Whole-Brain Protective Property by Promoting M1? Microglia Quiescence After Experimental Subarachnoid Hemorrhage in Mice.
    Pang J; Peng J; Matei N; Yang P; Kuai L; Wu Y; Chen L; Vitek MP; Li F; Sun X; Zhang JH; Jiang Y
    Transl Stroke Res; 2018 Dec; 9(6):654-668. PubMed ID: 30225551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen receptors and ischemic neuroprotection: who, what, where, and when?
    Schreihofer DA; Ma Y
    Brain Res; 2013 Jun; 1514():107-22. PubMed ID: 23500634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
    Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
    Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced histamine levels and H3 receptor antagonist-induced histamine release in the amygdala of Apoe-/- mice.
    van Meer P; Pfankuch T; Raber J
    J Neurochem; 2007 Oct; 103(1):124-30. PubMed ID: 17573822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
    Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marked hippocampal neuronal damage without motor deficits after mild concussive-like brain injury in apolipoprotein E-deficient mice.
    Han SH; Chung SY
    Ann N Y Acad Sci; 2000 Apr; 903():357-65. PubMed ID: 10818526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ApoE and Neurodegenerative Diseases in Aging.
    Yin Y; Wang Z
    Adv Exp Med Biol; 2018; 1086():77-92. PubMed ID: 30232753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral phenotype and BDNF differences related to apoE isoforms and sex in young transgenic mice.
    Reverte I; Klein AB; Ratner C; Domingo JL; Colomina MT
    Exp Neurol; 2012 Sep; 237(1):116-25. PubMed ID: 22735491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.